- Home
- CORT vs BXSL Comparison
CORT vs BXSL Comparison
Compare CORT & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- BXSL
- Stock Information
- Founded
- CORT 1998
- BXSL 2018
- Country
- CORT United States
- BXSL United States
- Employees
- CORT N/A
- BXSL N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- BXSL Trusts Except Educational Religious and Charitable
- Sector
- CORT Health Care
- BXSL Finance
- Exchange
- CORT Nasdaq
- BXSL Nasdaq
- Market Cap
- CORT 7.1B
- BXSL 7.5B
- IPO Year
- CORT N/A
- BXSL N/A
- Fundamental
- Price
- CORT $75.08
- BXSL $31.65
- Analyst Decision
- CORT Strong Buy
- BXSL Buy
- Analyst Count
- CORT 4
- BXSL 6
- Target Price
- CORT $142.00
- BXSL $31.38
- AVG Volume (30 Days)
- CORT 1.3M
- BXSL 964.2K
- Earning Date
- CORT 05-05-2025
- BXSL 05-07-2025
- Dividend Yield
- CORT N/A
- BXSL 9.73%
- EPS Growth
- CORT 8.36
- BXSL N/A
- EPS
- CORT 1.14
- BXSL 3.14
- Revenue
- CORT $685,446,000.00
- BXSL $1,380,706,000.00
- Revenue This Year
- CORT $35.85
- BXSL $12.37
- Revenue Next Year
- CORT $35.22
- BXSL $8.12
- P/E Ratio
- CORT $65.80
- BXSL $10.08
- Revenue Growth
- CORT 30.93
- BXSL 16.76
- 52 Week Low
- CORT $25.35
- BXSL $25.89
- 52 Week High
- CORT $117.33
- BXSL $34.64
- Technical
- Relative Strength Index (RSI)
- CORT 57.68
- BXSL 64.90
- Support Level
- CORT $68.86
- BXSL $29.07
- Resistance Level
- CORT $73.36
- BXSL $30.04
- Average True Range (ATR)
- CORT 3.26
- BXSL 0.52
- MACD
- CORT 0.12
- BXSL 0.34
- Stochastic Oscillator
- CORT 95.28
- BXSL 98.20
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.